1. Home
  2. INVX vs TARS Comparison

INVX vs TARS Comparison

Compare INVX & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVX
  • TARS
  • Stock Information
  • Founded
  • INVX 2024
  • TARS 2016
  • Country
  • INVX United States
  • TARS United States
  • Employees
  • INVX N/A
  • TARS N/A
  • Industry
  • INVX
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • INVX
  • TARS Health Care
  • Exchange
  • INVX NYSE
  • TARS Nasdaq
  • Market Cap
  • INVX 1.1B
  • TARS 1.2B
  • IPO Year
  • INVX N/A
  • TARS 2020
  • Fundamental
  • Price
  • INVX $15.24
  • TARS $33.89
  • Analyst Decision
  • INVX
  • TARS Strong Buy
  • Analyst Count
  • INVX 0
  • TARS 5
  • Target Price
  • INVX N/A
  • TARS $51.60
  • AVG Volume (30 Days)
  • INVX 428.2K
  • TARS 548.9K
  • Earning Date
  • INVX 11-11-2024
  • TARS 11-07-2024
  • Dividend Yield
  • INVX N/A
  • TARS N/A
  • EPS Growth
  • INVX N/A
  • TARS N/A
  • EPS
  • INVX 3.71
  • TARS N/A
  • Revenue
  • INVX $530,575,000.00
  • TARS $83,374,000.00
  • Revenue This Year
  • INVX N/A
  • TARS $846.12
  • Revenue Next Year
  • INVX N/A
  • TARS $70.19
  • P/E Ratio
  • INVX $4.04
  • TARS N/A
  • Revenue Growth
  • INVX 13.57
  • TARS 566.99
  • 52 Week Low
  • INVX $14.07
  • TARS $12.57
  • 52 Week High
  • INVX $26.75
  • TARS $42.50
  • Technical
  • Relative Strength Index (RSI)
  • INVX N/A
  • TARS 60.85
  • Support Level
  • INVX N/A
  • TARS $31.66
  • Resistance Level
  • INVX N/A
  • TARS $33.66
  • Average True Range (ATR)
  • INVX 0.00
  • TARS 1.74
  • MACD
  • INVX 0.00
  • TARS -0.18
  • Stochastic Oscillator
  • INVX 0.00
  • TARS 67.93

About INVX INNOVEX INTERNATIONAL INC

Innovex International Inc designs, manufactures, and installs mission-critical drilling & deployment, well construction, completion, production, and fishing & intervention solutions to support upstream onshore and offshore activities worldwide. Its comprehensive portfolio extends throughout the lifecycle of the well; and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer. With locations throughout North America, Latin America, Europe, the Middle East, and Asia, The team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: